Identification of Adipokine Clusters Related to Parameters of Fat Mass, Insulin Sensitivity and Inflammation
暂无分享,去创建一个
M. Fasshauer | M. Stumvoll | M. Scholz | A. Tönjes | M. Blüher | N. Klöting | Byung-Soo Youn | G. Flehmig
[1] J. Chudek,et al. Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome , 2014, Clinical endocrinology.
[2] Jennifer R. Harris,et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies , 2014, BMC Endocrine Disorders.
[3] Karel G M Moons,et al. Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing models. , 2014, The lancet. Diabetes & endocrinology.
[4] H. Randeva,et al. Metformin increases the novel adipokine cartonectin/CTRP3 in women with polycystic ovary syndrome. , 2013, The Journal of clinical endocrinology and metabolism.
[5] P. Scherer,et al. Adiponectin, driver or passenger on the road to insulin sensitivity? , 2013, Molecular metabolism.
[6] M. Blüher. Adipose tissue dysfunction contributes to obesity related metabolic diseases. , 2013, Best practice & research. Clinical endocrinology & metabolism.
[7] H. J. Yoo,et al. Implication of Progranulin and C1q/TNF-Related Protein-3 (CTRP3) on Inflammation and Atherosclerosis in Subjects with or without Metabolic Syndrome , 2013, PloS one.
[8] Zhengai Xiong,et al. Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans. , 2013, The Journal of clinical endocrinology and metabolism.
[9] C. Kahn,et al. Glypican-4 Enhances Insulin Signaling via Interaction With the Insulin Receptor and Serves as a Novel Adipokine , 2012, Diabetes.
[10] M. Green,et al. Association between serum retinol-binding protein 4 concentrations and clinical indices in subjects with type 2 diabetes: a meta-analysis. , 2012, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.
[11] E. Benjamin,et al. Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study , 2012, Diabetology & Metabolic Syndrome.
[12] P. Scherer,et al. Adiponectin: mechanistic insights and clinical implications , 2012, Diabetologia.
[13] M. Fasshauer,et al. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. , 2012, Metabolism: clinical and experimental.
[14] M. Stampfer,et al. Two Patterns of Adipokine and Other Biomarker Dynamics in a Long-Term Weight Loss Intervention , 2012, Diabetes Care.
[15] S. Kitazawa,et al. PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue. , 2012, Cell metabolism.
[16] S. Hartwig,et al. Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders , 2012, Proteomics. Clinical applications.
[17] H. Park,et al. Relationship between vaspin gene expression and abdominal fat distribution of Korean women. , 2011, Endocrine journal.
[18] Bing Chen,et al. Serum bone morphogenetic protein 7, insulin resistance, and insulin secretion in non-diabetic individuals. , 2011, Diabetes research and clinical practice.
[19] L. Lynch,et al. Preadipocyte factor-1 is associated with metabolic profile in severe obesity. , 2011, The Journal of clinical endocrinology and metabolism.
[20] G. Kottas,et al. Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[21] C. Liapis,et al. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes. , 2010, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[22] M. Laakso,et al. A novel surrogate index for hepatic insulin resistance , 2011, Diabetologia.
[23] E. Wijsman,et al. Low Clusterin Levels in High-Density Lipoprotein Associate With Insulin Resistance, Obesity, and Dyslipoproteinemia , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[24] M. Fasshauer,et al. Adipokine Pattern in Subjects with Impaired Fasting Glucose and Impaired Glucose Tolerance in Comparison to Normal Glucose Tolerance and Diabetes , 2010, PloS one.
[25] H. Randeva,et al. Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome , 2010, Diabetes.
[26] M. Fasshauer,et al. Insulin-sensitive obesity. , 2010, American journal of physiology. Endocrinology and metabolism.
[27] K. Kristiansen,et al. Cross Talk between Insulin and Bone Morphogenetic Protein Signaling Systems in Brown Adipogenesis , 2010, Molecular and Cellular Biology.
[28] J. Moreno-Navarrete,et al. Circulating omentin concentration increases after weight loss , 2010, Nutrition & metabolism.
[29] W. Rathmann,et al. Prevalence of undiagnosed diabetes and impaired glucose regulation in 35–59‐year‐old individuals in Southern Germany: the KORA F4 Study , 2010, Diabetic medicine : a journal of the British Diabetic Association.
[30] J. Mauer,et al. Visfatin/PBEF/Nampt and Resistin Expressions in Circulating Blood Monocytes are Differentially Related to Obesity and Type 2 Diabetes in Humans , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[31] Massimo Midiri,et al. Visceral Adiposity Index , 2010, Diabetes Care.
[32] Puy Garrastachu,et al. BAT: a new target for human obesity? , 2009, Trends in pharmacological sciences.
[33] H. Randeva,et al. Insulin and Metformin Regulate Circulating and Adipose Tissue Chemerin , 2009, Diabetes.
[34] M. Blüher,et al. Adipose tissue dysfunction in obesity. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[35] M. Fasshauer,et al. Serum Progranulin Concentrations May Be Associated With Macrophage Infiltration Into Omental Adipose Tissue , 2009, Diabetes.
[36] C. Kahn,et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure , 2008, Nature.
[37] H. Randeva,et al. Metformin Decreases the Adipokine Vaspin in Overweight Women With Polycystic Ovary Syndrome Concomitant With Improvement in Insulin Sensitivity and a Decrease in Insulin Resistance , 2008, Diabetes.
[38] R. Rabasa-Lhoret,et al. Metabolically healthy but obese women: effect of an energy-restricted diet , 2008, Diabetologia.
[39] G. Bray,et al. Adiponectin, Change in Adiponectin, and Progression to Diabetes in the Diabetes Prevention Program , 2008, Diabetes.
[40] M. Fasshauer,et al. Serum Vaspin Concentrations in Human Obesity and Type 2 Diabetes , 2008, Diabetes.
[41] P. Zimmet,et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. , 2007, Endocrinology.
[42] E. Butcher,et al. Chemerin, a Novel Adipokine That Regulates Adipogenesis and Adipocyte Metabolism* , 2007, Journal of Biological Chemistry.
[43] M. Fasshauer,et al. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. , 2007, Cell metabolism.
[44] A. Shuldiner,et al. Omentin Plasma Levels and Gene Expression Are Decreased in Obesity , 2007, Diabetes.
[45] P. Kern,et al. Ectopic fat accumulation and metabolic syndrome , 2007, Diabetes, obesity & metabolism.
[46] G. Hotamisligil,et al. Inflammation and metabolic disorders , 2006, Nature.
[47] C. Block,et al. Mechanisms linking obesity with cardiovascular disease , 2006, Nature.
[48] Arya M. Sharma,et al. Retinol-Binding Protein 4 in Human Obesity , 2006, Diabetes.
[49] B. Heude,et al. Serum adiponectin is related to plasma high-density lipoprotein cholesterol but not to plasma insulin-concentration in healthy children: the FLVS II study. , 2006, Metabolism: clinical and experimental.
[50] U. Smith,et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. , 2006, The New England journal of medicine.
[51] Hidetoshi Shimodaira,et al. Pvclust: an R package for assessing the uncertainty in hierarchical clustering , 2006, Bioinform..
[52] Jacqueline Capeau,et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. , 2006, European cytokine network.
[53] R. Ross,et al. Visceral Fat Is an Independent Predictor of All‐cause Mortality in Men , 2006, Obesity.
[54] M. Fasshauer,et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. , 2006, Biochemical and biophysical research communications.
[55] M. Fasshauer,et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. , 2005, Diabetes.
[56] Eijiro Watanabe,et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[57] Marc Parmentier,et al. Specific Recruitment of Antigen-presenting Cells by Chemerin, a Novel Processed Ligand from Human Inflammatory Fluids , 2003, The Journal of experimental medicine.
[58] T. Saruta,et al. Correlation between serum resistin level and adiposity in obese individuals. , 2003, Obesity research.
[59] H. Boeing,et al. Adiponectin and protection against type 2 diabetes mellitus , 2003, The Lancet.
[60] G. Gallus,et al. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. , 2003, Diabetes care.
[61] R. Paschke,et al. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. , 2002, Biochemical and biophysical research communications.
[62] T. Funahashi,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .
[63] S. O’Rahilly,et al. The perils of portliness: causes and consequences of visceral adiposity. , 2000, Diabetes.
[64] E. Ferrannini,et al. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). , 1997, The Journal of clinical investigation.